Cargando…
Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
Prostate cancer is a disease of older adults that has undergone a significant therapeutic paradigm shift in the last decade with the emergence of novel androgen receptor pathway inhibitors (ARPis). One of the more commonly used ARPis is enzalutamide. This drug, along with darolutamide and apalutamid...
Autores principales: | Mir, Nabiel, Burke, Olivia, Yates, Samuel, Rajasekaran, Tanujaa, Chan, Johan, Szmulewitz, Russell, Kanesvaran, Ravindran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893362/ https://www.ncbi.nlm.nih.gov/pubmed/36743522 http://dx.doi.org/10.1177/17588359221149887 |
Ejemplares similares
-
Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients
por: Tan, Tira, et al.
Publicado: (2016) -
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology
por: Droz, Jean-Pierre, et al.
Publicado: (2010) -
Updated International Society of Geriatric Oncology COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer
por: Soto-Perez-de-Celis, Enrique, et al.
Publicado: (2022) -
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective
por: Desideri, Isacco, et al.
Publicado: (2020) -
Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
por: Kregel, Steven, et al.
Publicado: (2013)